Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_assertion type Assertion NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_head.
- NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_assertion description "[Moreover, the carriage of both MIP-1alpha -906 (TA)(6)/(TA)(6) genotype and ApoE epsilon4+ genotype confers greater risk for the development of UC (P < 0.001, OR = 5.432, 95% CI 2.761-10.689).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_provenance.
- NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_assertion evidence source_evidence_literature NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_provenance.
- NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_assertion SIO_000772 18762952 NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_provenance.
- NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_assertion wasDerivedFrom gad-20130706 NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_provenance.
- NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_assertion wasGeneratedBy ECO_0000203 NP71665.RAuZfp1sqQSoftAdUeGflwK9pfeFky8AgTCcXnBwxg2A0130_provenance.